These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12873745)

  • 1. Both alpha1-adrenergic and D(1)-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice.
    Cheng JT; Kuo DY
    Neurosci Lett; 2003 Aug; 347(2):136-8. PubMed ID: 12873745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the alpha 1a-adrenoceptor antagonist RS-17053 on phenylpropanolamine-induced anorexia in rats.
    Wellman PJ; McMahon LR; Green T; Tole A
    Pharmacol Biochem Behav; 1997; 57(1-2):281-4. PubMed ID: 9164583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the alpha 1-receptor antagonist prazosin.
    Wellman PJ; Davies BT
    Pharmacol Biochem Behav; 1992 May; 42(1):97-100. PubMed ID: 1356275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of adrenergic anorectic agents.
    Wellman PJ
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):193S-198S. PubMed ID: 1309478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of dopamine D(1) and D(2) receptors in mediating the decrease of food intake during repeated treatment with amphetamine.
    Chen TY; Duh SL; Huang CC; Lin TB; Kuo DY
    J Biomed Sci; 2001; 8(6):462-6. PubMed ID: 11702009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat.
    Axel AM; Mikkelsen JD; Hansen HH
    Neuropsychopharmacology; 2010 Jun; 35(7):1464-76. PubMed ID: 20200509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression.
    Hsieh YS; Hsu JD; Yang SF; Kuo DY
    Peptides; 2004 Dec; 25(12):2155-61. PubMed ID: 15572205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test.
    Hirano S; Miyata S; Onodera K; Kamei J
    Eur J Pharmacol; 2007 May; 562(1-2):72-6. PubMed ID: 17328889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the involvement of paraventricular hypothalamic alpha 2-adrenoceptors in phenylpropanolamine anorexia.
    Davies BT; Wellman PJ; Morien A
    Physiol Behav; 1993 Jul; 54(1):121-8. PubMed ID: 8392206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ICV administration of the alpha1A-adrenoceptor antagonist 5-methylurapidil on concurrent measures of eating and locomotion after cocaine in the rat.
    Clifford PS; Davis KW; Elliott AE; Wellman PJ
    Life Sci; 2007 Sep; 81(13):1059-65. PubMed ID: 17881010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic neurotransmission in the rat testicular capsule: functional characterization and identification of mRNA encoding alpha1-adrenoceptor subtypes.
    Jurkiewicz NH; Caricati-Neto A; Verde LF; Avellar MC; Reuter HR; Jurkiewicz A
    Eur J Pharmacol; 2006 Aug; 543(1-3):141-50. PubMed ID: 16822496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics.
    Gioanni Y; Thierry AM; Glowinski J; Tassin JP
    Synapse; 1998 Dec; 30(4):362-70. PubMed ID: 9826228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the role of oxytocin receptors in phenylpropanolamine-induced anorexia in rats.
    McMahon LR; Wellman PJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):767-70. PubMed ID: 9259004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the subtypes of alpha1-adrenoceptor mediating contractions of rat vas deferens.
    Honner V; Docherty JR
    Br J Pharmacol; 1999 Nov; 128(6):1323-31. PubMed ID: 10578148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of D1 and alpha1 receptors in the enhanced locomotor response to dopamine D2-like receptor stimulation induced by repeated electroconvulsive shock.
    D'Aquila PS; Collu M; Gessa GL; Serra G
    J Psychopharmacol; 1997; 11(1):41-4. PubMed ID: 9097892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of phenylpropanolamine anorexia in rats by the alpha-1 receptor antagonist benoxathian.
    Wellman PJ; Davies BT
    Pharmacol Biochem Behav; 1991 Apr; 38(4):905-8. PubMed ID: 1678528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of protein kinase Calpha isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression.
    Kuo DY; Yang SF; Chu SC; Chen CH; Hsieh YS
    J Neurochem; 2009 Mar; 108(6):1495-506. PubMed ID: 19183253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.